Aim Human inducible pluripotent stem cell-derived cardiomyocytes (hiPSC-CM) have an immature phenotype including a glycolytic metabolism. Here we aimed to mature the metabolic status of beating (hiPSC-CM) by targeting the PPAR-α pathway, which regulates the transcription of genes involved in fatty acid metabolism. We cultured hiPSC-CM with the fatty acid Oleic Acid (OA) with or without the PPAR-α agonist WY14643.
Methods hiPSCs cells were differentiated into beating hiPSC-CM by treatment with CHIR99021 followed by IWP4. Beating hiPSC-CM were treated with 400 uM OA with or without 120 uM WY14643 for 8 and 24 hours. Oxygen consumption was measured using a Clark-type oxygen electrode, glycolysis was measured by addition of 3H-glucose. Gene expression was measured using qPCR.
Results A significant increase in oxygen consumption and reserve respiratory capacity when respiring on fatty acid was?observed in beating iPSC-CM after culture with OA ±WY14643 for 24 hours compared with untreated and OA-treated hiPSC-CM. OA ±WY14643 caused a significant increase in expression of carnitine palmitoyltransferase 1B, medium chain acyl-CoA dehydrogenase and pyruvate dehydrogenase kinase after 8 hours whilst expression of glucose transporters and phosphofructokinase decreased. Addition of OA, but not OA ±WY14643, increased the rate of O2 respiration on pyruvate and malate but not the reserve respiratory capacity. There was no change in the rate of glycoysis after treatment with OA ±WY14643 for 24 hours.
Conclusion Treatment with OA and WY14643 for 24 hours increased fatty acid utilisation in beating hiPSC-derived cardiomyoyctes. Funded by the BHF and the Qatar Foundation.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.